Vyne Therapeutics Inc. · NASDAQ:VYNE
Citadel Advisors LLC's stake in Vyne Therapeutics Inc. fell below 5% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Citadel Advisors LLC's stake in Vyne Therapeutics Inc. fell below 5%, 3,669 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 3,669
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 0% | 3,669 |
| Citadel Advisors Holdings LP | 0% | 3,669 |
| Citadel GP LLC | 0% | 3,669 |
| Citadel Securities LLC | 0% | 63 |
| Citadel Securities Group LP | 0% | 63 |
| Citadel Securities GP LLC | 0% | 63 |
| Kenneth Griffin | 0% | 3,732 |
Source
Related
- Vyne Therapeutics Inc.
- Citadel Advisors LLC
- Vyne Therapeutics Inc. shareholders
- Schedule 13G/A · Citadel Advisors LLC · May 15, 2025
- Form 4 · Zeronda Tyler · Jul 24, 2026
- Form 4 · Stuart Iain · Jul 24, 2026
- Form 4 · Harsch Mutya · Jul 24, 2026
- Form 4 · Domzalski David · Jul 24, 2026
- Schedule 13G/A · Zhang Xiaofan · Jul 17, 2026